台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    66.6
  • 漲跌
    ▼0.9
  • 漲幅
    -1.33%
  • 成交量
    208
  • 產業
    上櫃 生技醫療類股
  • 71人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
易威 (1799)籌碼相關-宏遠-台中 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw05/0405/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1002/0402/1602/2603/1003/2004/0104/0355606570758085May '24Jul '24Sep '24Nov '24Jan '25Mar '2560d90dAll

宏遠-台中 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/03/2700.00273.5073.60-2573-0.35%
2025/03/25275.8000.0076.0025940.34%
2025/03/2400.00272.3072.20-2593-0.34%
2025/03/20173.8000.0073.1015950.17%
2025/03/19173.2000.0072.6015980.17%
2025/03/18476.1000.0075.5046020.66%
2025/03/1700.00179.0077.50-1616-0.16%
2025/03/14377.4300.0077.7036170.49%
2025/03/1300.00379.8081.00-3603-0.50%
2025/03/12378.27379.2077.5005850.00%
2025/03/11178.4000.0081.5015570.18%
2025/03/10175.90172.0076.8005180.00%
2025/03/07371.53469.8069.90-1496-0.20%
2025/03/06268.1000.0067.6024830.41%
2025/03/05269.0000.0068.9024840.41%
2025/03/0400.00569.0869.60-5483-1.03%
2025/03/03364.501367.8269.60-10483-2.07%
2025/02/26266.6000.0066.4024900.41%
2025/02/24267.1500.0068.0025040.40%
2025/02/21668.77267.6067.8045080.79%
2025/02/20268.7000.0071.0024970.40%
2025/02/19365.37363.9365.5004900.00%
2025/02/18162.2000.0062.6015020.20%
2025/02/17463.10263.8062.2025210.38%
2025/02/14162.1000.0063.0015430.18%
2025/02/13161.20263.6062.80-1574-0.17%
2025/02/12262.20261.3061.9005850.00%
2025/02/11265.1000.0064.0025940.34%
2025/02/0400.00161.0060.70-1605-0.17%
2025/01/1300.00162.6062.80-1627-0.16%
2025/01/10164.5000.0065.4016240.16%
2024/12/3100.00564.0464.30-5669-0.75%
2024/12/2700.00163.8063.30-1697-0.14%
2024/12/25176.3000.0074.0016830.15%
2024/12/24471.4000.0073.0046770.59%
2024/12/23165.80566.0066.40-4680-0.59%
2024/12/18157.2000.0060.9016780.15%
2024/12/1600.00156.1054.50-1679-0.15%
2024/12/12154.50255.8054.90-1678-0.15%
2024/12/11254.9000.0054.9026660.30%
2024/12/0900.00162.3062.00-1646-0.15%
2024/12/06364.7700.0064.3036510.46%
2024/12/04166.6000.0067.0016550.15%
2024/11/25171.9000.0071.9016810.15%
2024/11/2200.00171.5073.00-1672-0.15%
2024/11/21167.6000.0068.0016620.15%
2024/11/1400.00268.4569.00-2670-0.30%
2024/11/12265.35269.0070.0006320.00%
2024/11/08277.8000.0077.8026030.33%
2024/11/0700.00185.7086.10-1620-0.16%
2024/11/06184.60187.1085.2006340.00%
2024/11/05184.6000.0084.9016360.16%
2024/10/2800.00396.5795.50-3688-0.44%
2024/10/253106.0000.00100.0036870.44%
2024/10/2200.001104.50107.00-1726-0.14%
2024/10/211101.502106.25105.50-1736-0.14%
2024/10/181110.004118.00110.00-3768-0.39%
2024/10/176120.5000.00122.0067790.77%
2024/10/1400.002.4115.52121.00-2.4817-0.29%
2024/10/112.4115.003.4118.21114.50-1824-0.12%
2024/10/093.4116.3800.00119.003.48380.40%
2024/10/0800.002124.50126.00-2839-0.24%
2024/10/0700.0017113.91116.50-17830-2.05%
2024/10/041789.271096.75106.5078130.86%
2024/10/0110.198.87198.0097.209.17871.16%
2024/09/302.1108.2400.00108.002.17770.27%
2024/09/270.1120.0000.00120.000.17960.01%
2024/09/261.1133.0000.00133.001.17850.14%
2024/09/160.1175.0000.00175.500.17800.01%
2024/09/040.1208.0000.00207.000.18020.01%
2024/08/1400.000.2190.00192.00-0.2841-0.02%
2024/08/060.2174.0000.00171.000.27770.03%
2024/07/3100.000.4152.50161.00-0.4727-0.06%
2024/07/300.4142.501146.50148.00-0.6716-0.08%
2024/07/291139.502144.50141.50-1708-0.14%
2024/07/261151.501155.50148.0007000.00%
2024/07/231153.001160.50160.0006850.00%
2024/07/221164.5000.00164.0016670.15%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音
 
 
06小時15